| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Pierre Paoletti | Q42943550 |
| P2093 | author name string | Jacques Neyton | |
| P433 | issue | 1 | |
| P921 | main subject | pharmacology | Q128406 |
| P304 | page(s) | 39-47 | |
| P577 | publication date | 2006-11-07 | |
| P1433 | published in | Current Opinion in Pharmacology | Q3007702 |
| P1476 | title | NMDA receptor subunits: function and pharmacology | |
| P478 | volume | 7 |
| Q92490635 | 1H-Pyrrolo[3,2-b]pyridine GluN2B-Selective Negative Allosteric Modulators |
| Q50740072 | 3-Mercaptopropionic acid-induced repetitive seizures increase GluN2A expression in rat hippocampus: a potential neuroprotective role of cyclopentyladenosine |
| Q42972119 | 3-mercaptopropionic acid-induced seizures decrease NR2B expression in Purkinje cells: cyclopentyladenosine effect. |
| Q43280905 | 4,4-Dimethyl- and diastereomeric 4-hydroxy-4-methyl- (2S)-glutamate analogues display distinct pharmacological profiles at ionotropic glutamate receptors and excitatory amino acid transporters |
| Q36580288 | A Mutation in DAOA Modifies the Age of Onset in PSEN1 E280A Alzheimer's Disease |
| Q37141200 | A NMDA receptor glycine site partial agonist, GLYX-13, simultaneously enhances LTP and reduces LTD at Schaffer collateral-CA1 synapses in hippocampus |
| Q36673772 | A family of photoswitchable NMDA receptors |
| Q47160324 | A high-throughput model for investigating neuronal function and synaptic transmission in cultured neuronal networks. |
| Q33450644 | A new family of receptor tyrosine kinases with a venus flytrap binding domain in insects and other invertebrates activated by aminoacids |
| Q27319948 | A role for calcium-permeable AMPA receptors in synaptic plasticity and learning |
| Q42837575 | A specific class of interneuron mediates inhibitory plasticity in the lateral amygdala |
| Q34171285 | Activation of NR2A receptors induces ischemic tolerance through CREB signaling |
| Q48154493 | Activity-dependent control of NMDA receptor subunit composition at hippocampal mossy fibre synapses |
| Q37613295 | Activity-dependent synaptic plasticity of NMDA receptors. |
| Q36866942 | Acute 5-HT7 receptor activation increases NMDA-evoked currents and differentially alters NMDA receptor subunit phosphorylation and trafficking in hippocampal neurons |
| Q38218083 | Advances in non-dopaminergic treatments for Parkinson's disease |
| Q39210660 | Afferent Input Selects NMDA Receptor Subtype to Determine the Persistency of Hippocampal LTP in Freely Behaving Mice |
| Q36392889 | All atom NMDA receptor transmembrane domain model development and simulations in lipid bilayers and water. |
| Q57060009 | All-optical synaptic electrophysiology probes mechanism of ketamine-induced disinhibition |
| Q46543438 | Allosteric Inhibitors of NMDA Receptor Functions. |
| Q91924117 | Allosteric Modulators of Potential Targets Related to Alzheimer's Disease: a Review |
| Q37548763 | Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential |
| Q45591493 | Alterations of NMDA receptor subunits NR1, NR2A and NR2B mRNA expression and their relationship to apoptosis following transient forebrain ischemia |
| Q54966162 | Amelioration of Pentylenetetrazole-Induced Seizures by Modulators of Sigma, N-Methyl-D-Aspartate, and Ryanodine Receptors in Mice. |
| Q28571825 | Amino terminal domains of the NMDA receptor are organized as local heterodimers |
| Q54410821 | Amygdala gene expression of NMDA and GABA(A) receptors in patients with mesial temporal lobe epilepsy. |
| Q33798598 | Amygdalar glutamatergic neuronal systems play a key role on the hibernating state of hamsters. |
| Q35912672 | An Integrated Approach for Screening and Identification of Positive Allosteric Modulators of N-Methyl-D-Aspartate Receptors |
| Q37683489 | Analgesic Effects of Preincision Ketamine on Postspinal Caesarean Delivery in Uganda's Tertiary Hospital: A Randomized Clinical Trial. |
| Q34936108 | Analysis of variations in the glutamate receptor, N-methyl D-aspartate 2A (GRIN2A) gene reveals their relative importance as genetic susceptibility factors for heroin addiction |
| Q33691498 | Antagonistic action on NMDA/GluN2B mediated currents of two peptides that were conantokin-G structure-based designed |
| Q38248566 | Antipsychotic treatment modulates glutamate transport and NMDA receptor expression |
| Q35514700 | Arrangement of subunits in functional NMDA receptors |
| Q91975779 | Assessment of NMDA receptor inhibition of phencyclidine analogues using a high-throughput drebrin immunocytochemical assay |
| Q35626932 | Association study indicates a protective role of phosphatidylinositol-4-phosphate-5-kinase against tardive dyskinesia |
| Q37378254 | Atomoxetine affects transcription/translation of the NMDA receptor and the norepinephrine transporter in the rat brain--an in vivo study |
| Q30486391 | Atypical anti-schizophrenic drugs prevent changes in cortical N-methyl-D-aspartate receptors and behavior following sub-chronic phencyclidine administration in developing rat pups |
| Q91867564 | Can N-Methyl-D-Aspartate Receptor Hypofunction in Schizophrenia Be Localized to an Individual Cell Type? |
| Q40899995 | Changes in cortical N-methyl-D-aspartate receptors and post-synaptic density protein 95 in schizophrenia, mood disorders and suicide. |
| Q37192031 | Changes in striatal signaling induce remodeling of RGS complexes containing Gbeta5 and R7BP subunits |
| Q27316321 | Characterisation of the expression of NMDA receptors in human astrocytes |
| Q36345486 | Chemical coding of zinc-enriched neurons in the intramural ganglia of the porcine jejunum. |
| Q26770781 | Chronic Glutamate Toxicity in Neurodegenerative Diseases-What is the Evidence? |
| Q31103465 | Chronic zinc exposure decreases the surface expression of NR2A-containing NMDA receptors in cultured hippocampal neurons. |
| Q33784099 | Co-agonists differentially tune GluN2B-NMDA receptor trafficking at hippocampal synapses |
| Q40742869 | Cocaine Experience Enhances Thalamo-Accumbens N-Methyl-D-Aspartate Receptor Function. |
| Q33626978 | Cocaine-induced neuroadaptations in glutamate transmission: potential therapeutic targets for craving and addiction |
| Q58735329 | Cognitive Function Recovery Pattern in Adult Patients With Severe Anti-N-Methyl-D-Aspartate Receptor Encephalitis: A Longitudinal Study |
| Q39353895 | Cognitive outcomes following anti-N-methyl-D-aspartate receptor encephalitis: A systematic review |
| Q51674319 | Colonic mucosal N-methyl-D-aspartate receptor mediated visceral hypersensitivity in a mouse model of irritable bowel syndrome. |
| Q49118529 | Combined effect of genetic variants in the GluN2B coding gene (GRIN2B) on prefrontal function during working memory performance |
| Q33440753 | Combined strategies for the discovery of ionotropic glutamate receptor antagonists |
| Q49608374 | Comparative Pharmacological Study of Common NMDA Receptor Open Channel Blockers Regarding Their Affinity and Functional Activity toward GluN2A and GluN2B NMDA Receptors |
| Q37284675 | Comparative study of the effects of different growth hormone doses on growth and spatial performance of hypophysectomized rats |
| Q35669940 | Compound MQA, a Caffeoylquinic Acid Derivative, Protects Against NMDA-Induced Neurotoxicity and Potential Mechanisms In Vitro. |
| Q45283193 | Computational studies to discover a new NR2B/NMDA receptor antagonist and evaluation of pharmacological profile |
| Q36066712 | Conformational transitions in the glycine-bound GluN1 NMDA receptor LBD via single-molecule FRET. |
| Q38178749 | Contribution of transcriptional and translational mechanisms to the recovery aspect of sleep regulation |
| Q37981836 | Copper-dependent regulation of NMDA receptors by cellular prion protein: implications for neurodegenerative disorders. |
| Q52318194 | Cross state-dependency of learning between tramadol and MK-801 in the mouse dorsal hippocampus: involvement of nitric oxide (NO) signaling pathway. |
| Q27670452 | Crystal Structure of a Zinc-dependent D-Serine Dehydratase from Chicken Kidney |
| Q27655567 | Crystal structure and association behaviour of the GluR2 amino-terminal domain |
| Q58693044 | Current Concepts and Treatments of Schizophrenia |
| Q39307652 | Current Evidence of Chinese Herbal Constituents with Effects on NMDA Receptor Blockade |
| Q34326695 | Current and calcium responses to local activation of axonal NMDA receptors in developing cerebellar molecular layer interneurons |
| Q26798231 | Current and novel therapeutic molecules and targets in Alzheimer's disease |
| Q37523991 | Current approaches with the glutamatergic system as targets in the treatment of neuropathic pain |
| Q52654614 | Current therapeutic molecules and targets in neurodegenerative diseases based on in silico drug design. |
| Q59052088 | D-Serine in Neuropsychiatric Disorders: New Advances |
| Q38188664 | D-Serine in neurobiology: CNS neurotransmission and neuromodulation. |
| Q48649886 | D-serine-induced inactivation of NMDA receptors in cultured rat hippocampal neurons expressing NR2A subunits is Ca2+-dependent |
| Q26738425 | Defects of the Glycinergic Synapse in Zebrafish |
| Q37981280 | Dendritic calcium mechanisms and long-term potentiation in cortical inhibitory interneurons |
| Q38705814 | Design, synthesis, and structure-activity relationship of a novel series of GluN2C-selective potentiators. |
| Q53015251 | Development of PET and SPECT probes for glutamate receptors. |
| Q35003575 | Developmental expression of N-methyl-D-aspartate (NMDA) receptor subunits in human white and gray matter: potential mechanism of increased vulnerability in the immature brain |
| Q43602309 | Different NMDA receptor subtypes mediate induction of long-term potentiation and two forms of short-term potentiation at CA1 synapses in rat hippocampus in vitro. |
| Q34571443 | Differential phosphorylation of GluN1-MAPKs in rat brain reward circuits following long-term alcohol exposure |
| Q46905333 | Differential regulation of the NMDA receptor by acute and sub-chronic phencyclidine administration in the developing rat. |
| Q52346629 | Discovery and development of NA-1 for the treatment of acute ischemic stroke. |
| Q38117750 | Disruption of thalamocortical activity in schizophrenia models: relevance to antipsychotic drug action |
| Q35195550 | Distinct pharmacological and functional properties of NMDA receptors in mouse cortical astrocytes. |
| Q34746522 | Drugs and their molecular targets: an updated overview |
| Q47865702 | Dynamical differences of hemoglobin and the ionotropic glutamate receptor in different states revealed by a new dynamics alignment method. |
| Q50753745 | Dynamics and allostery of the ionotropic glutamate receptors and the ligand binding domain |
| Q90672250 | Effect of Chronic Administration of Nickel on Affective and Cognitive Behavior in Male and Female Rats: Possible Implication of Oxidative Stress Pathway |
| Q47166838 | Effect of low-dose ketamine on post-operative serum IL-6 production among elective surgical patients: a randomized clinical trial |
| Q47791105 | Effects of Hallucinogens on Neuronal Activity |
| Q40218300 | Effects of NMDA receptor antagonists with different subtype selectivities on retinal spreading depression |
| Q92152341 | Effects of Perioperative Magnesium Sulfate Administration on Postoperative Chronic Knee Pain in Patients Undergoing Total Knee Arthroplasty: A Retrospective Evaluation |
| Q34628396 | Effects of chronic oral treatment with aripiprazole on the expression of NMDA receptor subunits and binding sites in rat brain |
| Q64994163 | Efficacy of Simultaneous Administration of Nimodipine, Progesterone, and Magnesium Sulfate in Patients with Severe Traumatic Brain Injury: A Randomized Controlled Trial. |
| Q36100467 | Enantiopure Indolo[2,3-a]quinolizidines: Synthesis and Evaluation as NMDA Receptor Antagonists. |
| Q34598721 | Encoding of the cough reflex in anesthetized guinea pigs |
| Q47406465 | Engaging homeostatic plasticity to treat depression |
| Q30380441 | Environmental Enrichment Ameliorates Behavioral Impairments Modeling Schizophrenia in Mice Lacking Metabotropic Glutamate Receptor 5 |
| Q30415189 | Ethanol effects on N-methyl-D-aspartate receptors in the bed nucleus of the stria terminalis |
| Q38222885 | Ethanol neurotoxicity in the developing cerebellum: underlying mechanisms and implications |
| Q35554143 | Ethanol withdrawal is required to produce persisting N-methyl-D-aspartate receptor-dependent hippocampal cytotoxicity during chronic intermittent ethanol exposure |
| Q35577736 | Ethanol-mediated long-lasting adaptations of the NR2B-containing NMDA receptors in the dorsomedial striatum |
| Q84514109 | Evaluation of natural and nitramine binding energies to 3-D models of the S1S2 domains in the N-methyl-D-aspartate receptor |
| Q39663368 | Excitatory glycine responses of CNS myelin mediated by NR1/NR3 "NMDA" receptor subunits |
| Q27022081 | Execution of RIPK3-regulated necrosis |
| Q48867715 | Expression of NMDA receptor and its effect on cell proliferation in the subventricular zone of neonatal rat brain |
| Q42069029 | Extended daily access to cocaine results in distinct alterations in Homer 1b/c and NMDA receptor subunit expression within the medial prefrontal cortex |
| Q33328978 | Extensive neuroadaptive changes in cortical gene-transcript expressions of the glutamate system in response to repeated intermittent MDMA administration in adolescent rats |
| Q28487793 | Fluorescence-based high-throughput functional profiling of ligand-gated ion channels at the level of single cells |
| Q88011616 | Fluorinated GluN2B Receptor Antagonists with a 3-Benzazepine Scaffold Designed for PET Studies |
| Q34610614 | Fruit flies and intellectual disability |
| Q90150401 | Functional Role of SIL1 in Neurodevelopment and Learning |
| Q42474084 | Functional heterogeneity of NMDA receptors in rat substantia nigra pars compacta and reticulata neurones |
| Q48910324 | Functional ionotropic glutamate receptors on peripheral axons and myelin |
| Q42066094 | GABAA , NMDA and mGlu2 receptors tonically regulate inhibition and excitation in the thalamic reticular nucleus. |
| Q49052293 | Genetic variants of the NMDA receptor influence cortical excitability and plasticity in humans |
| Q28244768 | Ginsenoside Rd protects neurons against glutamate-induced excitotoxicity by inhibiting ca(2+) influx |
| Q49147545 | Glial D-serine gates NMDA receptors at excitatory synapses in prefrontal cortex |
| Q28577751 | GluN1-specific redox effects on the kinetic mechanism of NMDA receptor activation |
| Q37350719 | GluN2A and GluN2B subunit-containing NMDA receptors in hippocampal plasticity. |
| Q35826085 | GluN2A-/- Mice Lack Bidirectional Synaptic Plasticity in the Dentate Gyrus and Perform Poorly on Spatial Pattern Separation Tasks |
| Q35749789 | GluN2B subunit deletion reveals key role in acute and chronic ethanol sensitivity of glutamate synapses in bed nucleus of the stria terminalis. |
| Q37453433 | GluN2B subunit-containing NMDA receptor antagonists prevent Abeta-mediated synaptic plasticity disruption in vivo. |
| Q87544801 | GluN2B-selective N-methyl-D-aspartate (NMDA) receptor antagonists derived from 3-benzazepines: synthesis and pharmacological evaluation of benzo[7]annulen-7-amines |
| Q37326737 | Glutamate and capsaicin effects on trigeminal nociception I: Activation and peripheral sensitization of deep craniofacial nociceptive afferents |
| Q33957510 | Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies |
| Q34330678 | Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders. |
| Q37772543 | Glutamate receptor phosphorylation and trafficking in pain plasticity in spinal cord dorsal horn |
| Q37585401 | Glutamate receptors as therapeutic targets for Parkinson's disease |
| Q42612089 | Glutamate transporters prevent excessive activation of NMDA receptors and extrasynaptic glutamate spillover in the spinal dorsal horn |
| Q24648924 | Glutamatergic substrates of drug addiction and alcoholism |
| Q34829339 | Glutamatergic targets for enhancing extinction learning in drug addiction |
| Q49011515 | Glycine release provoked by disturbed Na⁺, Na⁺ and Ca²⁺ homeostasis in cerebellar nerve endings: roles of Ca²⁺ channels, Na⁺/Ca²⁺ exchangers and GlyT2 transporter reversal |
| Q48218946 | Hepatic encephalopathy induces site-specific changes in gene expression of GluN1 subunit of NMDA receptor in rat brain |
| Q37276058 | Heroin addiction in African Americans: a hypothesis-driven association study |
| Q36693295 | Hippocampal N-methyl-D-aspartate receptor subunit expression profiles in a mouse model of prenatal alcohol exposure. |
| Q34073903 | How adaptation of the brain to alcohol leads to dependence: a pharmacological perspective. |
| Q35053116 | Hypoxia limits inhibitory effects of Zn2+ on spreading depolarizations |
| Q51803316 | Identification of Synaptic Patterns of NMDA Receptor Subtypes Upon Direction-Selective Rabbit Retinal Ganglion Cells. |
| Q47882701 | Identification of potential Gly/NMDA receptor antagonists by cheminformatics approach: a combination of pharmacophore modelling, virtual screening and molecular docking studies |
| Q39153228 | Ifenprodil infusion in agranular insular cortex alters social behavior and vocalizations in rats exposed to moderate levels of ethanol during prenatal development. |
| Q48742959 | Ifenprodil reduces excitatory synaptic transmission by blocking presynaptic P/Q type calcium channels |
| Q37686949 | Immunohistochemical localization of ionotropic glutamate receptors in the rat red nucleus |
| Q39685182 | Immunosuppression by N-methyl-D-aspartate receptor antagonists is mediated through inhibition of Kv1.3 and KCa3.1 channels in T cells |
| Q46085589 | In utero exposure to cocaine delays postnatal synaptic maturation of glutamatergic transmission in the VTA. |
| Q36944372 | Induction- and conditioning-protocol dependent involvement of NR2B-containing NMDA receptors in synaptic potentiation and contextual fear memory in the hippocampal CA1 region of rats |
| Q33906149 | Influence of the NR3A subunit on NMDA receptor functions. |
| Q39220107 | Inhibition of N-methyl-D-aspartate-activated current by bis(7)-tacrine in HEK-293 cells expressing NR1/NR2A or NR1/NR2B receptors |
| Q37434371 | Inhibition of glycine transporter-1 in the dorsal vagal complex improves metabolic homeostasis in diabetes and obesity |
| Q38249959 | Interaction of metal ions with neurotransmitter receptors and potential role in neurodiseases |
| Q39396414 | Interferon-α induces neurotoxicity through activation of the type I receptor and the GluN2A subunit of the NMDA receptor |
| Q35069330 | Intracisternal administration of NR2 subunit antagonists attenuates the nociceptive behavior and p-p38 MAPK expression produced by compression of the trigeminal nerve root |
| Q34328380 | Intrathecal injection of spironolactone attenuates radicular pain by inhibition of spinal microglia activation in a rat model |
| Q38940235 | Investigating dynamic structural and mechanical changes of neuroblastoma cells associated with glutamate-mediated neurodegeneration. |
| Q39324877 | Investigational drugs in Phase I and Phase II for Levodopa-induced dyskinesias |
| Q42456519 | Involvement of NR2A- or NR2B-containing N-methyl-D-aspartate receptors in the potentiation of cortical layer 5 pyramidal neurone inputs depends on the developmental stage |
| Q37855929 | Ion channel blockers for the treatment of neuropathic pain |
| Q27004533 | Ion channels as drug targets in central nervous system disorders |
| Q43212884 | Kainate receptors and signal integration by NG2 glial cells |
| Q27008948 | Ketamine in adult cardiac surgery and the cardiac surgery Intensive Care Unit: an evidence-based clinical review |
| Q36551432 | Ketamine-induced neuronal damage and altered N-methyl-D-aspartate receptor function in rat primary forebrain culture |
| Q89527723 | Ketamine: The final frontier or another depressing end? |
| Q37107473 | Kv4.2 potassium channels segregate to extrasynaptic domains and influence intrasynaptic NMDA receptor NR2B subunit expression |
| Q37880646 | Kynurenines and intestinal neurotransmission: the role of N-methyl-D-aspartate receptors. |
| Q58763012 | Lack of the Actin Capping Protein, Eps8, Affects NMDA-Type Glutamate Receptor Function and Composition |
| Q89723642 | Less NMDA Receptor Binding in Dorsolateral Prefrontal Cortex and Anterior Cingulate Cortex Associated with Reported Early Life Adversity but Not Suicide |
| Q34252649 | Life extension factor klotho enhances cognition |
| Q33980883 | Ligands for ionotropic glutamate receptors |
| Q41604924 | Lipid Rafts: Linking Alzheimer's Amyloid-β Production, Aggregation, and Toxicity at Neuronal Membranes |
| Q48377970 | Loss of the preferential control over the striato-nigral direct pathway by striatal NMDA receptors in a rat model of Parkinson's disease |
| Q24622132 | MHC class I modulates NMDA receptor function and AMPA receptor trafficking |
| Q49544820 | Magnetofection™ of NMDA Receptor Subunits GluN1 and GluN2A Expression Vectors in Non-Neuronal Host Cells |
| Q28577591 | Mapping the high-affinity binding domain of 5-substituted benzimidazoles to the proximal N-terminus of the GluN2B subunit of the NMDA receptor |
| Q50528746 | Mechanism and properties of positive allosteric modulation of N-methyl-d-aspartate receptors by 6-alkyl 2-naphthoic acid derivatives. |
| Q35415834 | Mechanism for noncompetitive inhibition by novel GluN2C/D N-methyl-D-aspartate receptor subunit-selective modulators |
| Q43845642 | Mechanism of TiO2 nanoparticle-induced neurotoxicity in zebrafish (Danio rerio). |
| Q39858588 | Mechanism of differential control of NMDA receptor activity by NR2 subunits |
| Q21296639 | Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective GABA(A) Receptor Modulators? |
| Q34127075 | Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: insights from molecular, cellular and synaptic studies |
| Q43061597 | Memantine for the treatment of general neuropathic pain: a narrative review. |
| Q39153205 | Metabotropic and ionotropic glutamate receptors as potential targets for the treatment of alcohol use disorder |
| Q37280041 | Metabotropic glutamate receptor ligands as potential therapeutics for addiction |
| Q41818450 | Metabotropic glutamate receptors for Parkinson's disease therapy |
| Q40582666 | Metal toxicity at the synapse: presynaptic, postsynaptic, and long-term effects |
| Q41165539 | Metaplasticity gated through differential regulation of GluN2A versus GluN2B receptors by Src family kinases |
| Q39789060 | Mg2+ block properties of triheteromeric GluN1-GluN2B-GluN2D NMDA receptors on neonatal rat substantia nigra pars compacta dopaminergic neurones |
| Q46528810 | MicroRNA-217 suppresses homocysteine-induced proliferation and migration of vascular smooth muscle cells via N-methyl-D-aspartic acid receptor inhibition |
| Q39450031 | Modulating synaptic NMDA receptors |
| Q38931910 | Modulation of N-Methyl-D-Aspartate Receptors (NMDAR), Bcl-2 and C-Fos Gene Expressions on Exposure to Individual and Mixtures of Low Concentration Metals in Zebrafish (Danio rerio). |
| Q49885593 | Modulatory effect of glutamate GluR2 receptor on the caudal neurosecretory Dahlgren cells of the olive flounder, Paralichthys olivaceus. |
| Q37852112 | Molecular basis of NMDA receptor functional diversity. |
| Q38254691 | Molecular basis of positive allosteric modulation of GluN2B NMDA receptors by polyamines |
| Q46041477 | Molecular determinants of multiple effects of nickel on NMDA receptor channels |
| Q33917845 | Molecular mechanisms involved in the side effects of fatty acid amide hydrolase inhibitors: a structural phenomics approach to proteome-wide cellular off-target deconvolution and disease association. |
| Q57478268 | Multi-Target Approach for Drug Discovery against Schizophrenia |
| Q42920059 | Multi-level control of ionotropic glutamate receptor function |
| Q37375300 | Multiple roles of GluN2B-containing NMDA receptors in synaptic plasticity in juvenile hippocampus |
| Q41927894 | N-methyl-D-aspartate (NMDA) receptor composition modulates dendritic spine morphology in striatal medium spiny neurons. |
| Q43541681 | N-methyl-D-aspartate receptor antibody-associated movement disorder without encephalopathy |
| Q39965041 | N-methyl-D-aspartate receptor inhibition by an apolipoprotein E-derived peptide relies on low-density lipoprotein receptor-associated protein |
| Q39094282 | N-methyl-D-aspartate receptors in human erythroid precursor cells and in circulating red blood cells contribute to the intracellular calcium regulation |
| Q30474021 | N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia? |
| Q38114881 | NMDA Receptor Activity in Neuropsychiatric Disorders |
| Q37277388 | NMDA Receptor Antagonists for Treatment of Depression |
| Q61818140 | NMDA Receptors in Astrocytes: In Search for Roles in Neurotransmission and Astrocytic Homeostasis |
| Q55474333 | NMDA antagonists for treating the non-motor symptoms in Parkinson's disease. |
| Q46031607 | NMDA potentiation by visible light in the presence of a fluorescent neurosteroid analogue. |
| Q90052803 | NMDA receptor C-terminal signaling in development, plasticity, and disease |
| Q38079762 | NMDA receptor activation: two targets for two co-agonists |
| Q37806320 | NMDA receptor antagonists for the treatment of neuropathic pain |
| Q48617016 | NMDA receptor antagonists: tools in neuroscience with promise for treating CNS pathologies |
| Q52632229 | NMDA receptor blockade ameliorates abnormalities of spike firing of subthalamic nucleus neurons in a parkinsonian nonhuman primate. |
| Q28580426 | NMDA receptor couples Rac1-GEF Tiam1 to direct oligodendrocyte precursor cell migration |
| Q26997407 | NMDA receptor modulators: an updated patent review (2013-2014) |
| Q34577100 | NMDA receptor subunits in the adult rat hippocampus undergo similar changes after 5 minutes in an open field and after LTP induction |
| Q36660216 | NMDA receptors in clinical neurology: excitatory times ahead |
| Q48659334 | NMDA receptors participate in the progression of diabetic kidney disease by decreasing Cdc42-GTP activation in podocytes |
| Q39182931 | NMDA receptors: linking physiological output to biophysical operation. |
| Q47961234 | NMDAR antagonists for the treatment of diabetes mellitus-Current status and future directions. |
| Q39313026 | NR2A contributes to genesis and propagation of cortical spreading depression in rats. |
| Q37157389 | NR2B subunit of the NMDA glutamate receptor regulates appetite in the parabrachial nucleus |
| Q46885924 | NR2B- and NR2D-containing synaptic NMDA receptors in developing rat substantia nigra pars compacta dopaminergic neurones |
| Q35886482 | Negative modulation of NMDA receptor channel function by DREAM/calsenilin/KChIP3 provides neuroprotection? |
| Q47361284 | Neonatal Repeated Exposure to Isoflurane not Sevoflurane in Mice Reversibly Impaired Spatial Cognition at Juvenile-Age |
| Q42720493 | Neonatal inflammation produces selective behavioural deficits and alters N-methyl-D-aspartate receptor subunit mRNA in the adult rat brain |
| Q64085430 | Nerve Growth Factor Serum Levels Are Associated With Regional Gray Matter Volume Differences in Schizophrenia Patients |
| Q42697374 | Neural Plasticity Associated with Hippocampal PKA-CREB and NMDA Signaling Is Involved in the Antidepressant Effect of Repeated Low Dose of Yueju Pill on Chronic Mouse Model of Learned Helplessness. |
| Q38020960 | Neural antigen-specific autoimmune disorders. |
| Q36247720 | Neurochemical characterization of zinc transporter 3-like immunoreactive (ZnT3(+)) neurons in the intramural ganglia of the porcine duodenum |
| Q36615812 | Neuroendocrine control of the transition to reproductive senescence: lessons learned from the female rodent model |
| Q37977251 | Neuronal receptors as targets for the action of amyloid-beta protein (Aβ) in the brain |
| Q48604679 | Neuroprotection of Ro25-6981 Against Ischemia/Reperfusion-Induced Brain Injury via Inhibition of Autophagy |
| Q60937880 | Neuroprotective effects of dexmedetomidine against isoflurane-induced neuronal injury via glutamate regulation in neonatal rats |
| Q37106625 | Neuroscience of alcoholism: molecular and cellular mechanisms |
| Q36020776 | Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease |
| Q37782116 | New insights into the molecular mechanisms of general anaesthetics |
| Q37974709 | New pharmacological avenues for the treatment of L-DOPA-induced dyskinesias in Parkinson's disease: targeting glutamate and adenosine receptors |
| Q42954137 | Novel 3-carboxy- and 3-phosphonopyrazoline amino acids as potent and selective NMDA receptor antagonists: design, synthesis, and pharmacological characterization |
| Q26849614 | Novel NMDA receptor modulators: an update |
| Q58696563 | Novel Protein Kinase Inhibitors Related to Tau Pathology Modulate Tau Protein-Self Interaction Using a Luciferase Complementation Assay |
| Q37692191 | Novel strategies for the treatment of inflammatory hyperalgesia |
| Q37807432 | NovelN-methyl-d-aspartate receptor antagonists: a review of compounds patented since 2006 |
| Q47155700 | Nuclear pore complex plasticity during developmental process as revealed by super-resolution microscopy. |
| Q38076363 | Oligodendrocyte N-methyl-D-aspartate receptor signaling: insights into its functions |
| Q38202292 | Oligodendrocyte pathophysiology and treatment strategies in cerebral ischemia |
| Q38742586 | Opioid adjuvant strategy: improving opioid effectiveness |
| Q36923095 | Opposing action of conantokin-G on synaptically and extrasynaptically-activated NMDA receptors |
| Q34554563 | Oral ketamine in the palliative care setting: a review of the literature and case report of a patient with neurofibromatosis type 1 and glomus tumor-associated complex regional pain syndrome |
| Q60957194 | Overview on the Effects of -Acetylcysteine in Neurodegenerative Diseases |
| Q48565649 | Oxytocin regulates changes of extracellular glutamate and GABA levels induced by methamphetamine in the mouse brain |
| Q49102585 | Perinatal exposure to alcohol disturbs spatial learning and glutamate transmission-related gene expression in the adult hippocampus |
| Q39310986 | Peripheral Elevation of a Klotho Fragment Enhances Brain Function and Resilience in Young, Aging, and α-Synuclein Transgenic Mice |
| Q34307278 | Peripheral N‐methyl‐d‐aspartate receptors contribute to mechanical hypersensitivity in a rat model of inflammatory temporomandibular joint pain |
| Q50344665 | Pharmacological characterisation of ligand- and voltage-gated ion channels expressed in human iPSC-derived forebrain neurons |
| Q36226960 | Phosphorylation of NR2B NMDA subunits by protein kinase C in arcuate nucleus contributes to inflammatory pain in rats |
| Q30476116 | Plastic synaptic networks of the amygdala for the acquisition, expression, and extinction of conditioned fear |
| Q39279458 | Plasticity of synaptic glun receptors is required for the Src‐dependent induction of long‐term potentiation at CA3‐CA1 synapses |
| Q42161348 | Platelet-derived growth factor selectively inhibits NR2B-containing N-methyl-D-aspartate receptors in CA1 hippocampal neurons |
| Q35932619 | Polymorphisms in MicroRNA Genes And Genes Involving in NMDAR Signaling and Schizophrenia: A Case-Control Study in Chinese Han Population |
| Q48586766 | Potencies and unblocking kinetic properties of antagonists at recombinant human NMDA receptors in a Xenopus oocytes model |
| Q34140397 | Pre and post synaptic NMDA effects targeting Purkinje cells in the mouse cerebellar cortex |
| Q34166643 | Pre-synaptic glycine GlyT1 transporter--NMDA receptor interaction: relevance to NMDA autoreceptor activation in the presence of Mg2+ ions |
| Q35148975 | Pregnanolone sulfate promotes desensitization of activated NMDA receptors. |
| Q48548323 | Prenatal exposure to noise stress: anxiety, impaired spatial memory, and deteriorated hippocampal plasticity in postnatal life |
| Q36532314 | Presynaptic NMDA receptor-mediated modulation of excitatory neurotransmission in the mouse dorsal motor nucleus of the vagus |
| Q42707602 | Presynaptic NR2A-Containing NMDARs Are Required for LTD between the Amygdala and the Perirhinal Cortex: A Potential Mechanism for the Emotional Modulation of Memory?(1,2,3). |
| Q41994679 | Properties and molecular identity of NMDA receptors at synaptic and non-synaptic inputs in cerebellar molecular layer interneurons |
| Q34407890 | Properties of doublecortin expressing neurons in the adult mouse dentate gyrus |
| Q44316997 | Protein kinase C modulates NMDA receptors in the myenteric plexus of the guinea pig ileum during in vitro ischemia and reperfusion. |
| Q36996488 | Quantification of the novel N-methyl-d-aspartate receptor ligand [11C]GMOM in man |
| Q36408158 | REST-dependent epigenetic remodeling promotes the developmental switch in synaptic NMDA receptors. |
| Q48364623 | Radiolabelling of 1,4-disubstituted 3-[18F]fluoropiperidines and its application to new radiotracers for NR2B NMDA receptor visualization |
| Q50878925 | Rapid modulation of gene expression profiles in the telencephalon of male goldfish following exposure to waterborne sex pheromones. |
| Q37979291 | Recent advances in targeting the ionotropic glutamate receptors in treating schizophrenia |
| Q27006067 | Recent progress in understanding subtype specific regulation of NMDA receptors by G Protein Coupled Receptors (GPCRs) |
| Q48103375 | Reciprocal interactions between MK-801, sleep deprivation and recovery in modulating rat behaviour |
| Q34048560 | Reduced frontal glutamate + glutamine and N-acetylaspartate levels in patients with chronic schizophrenia but not in those at clinical high risk for psychosis or with first-episode schizophrenia |
| Q36569620 | Regulation of synaptic transmission by ambient extracellular glutamate |
| Q57470642 | Replacement of benzylpiperidine moiety by fluorinated phenylalkyl side chains for the development of novel GluN2B receptor ligands |
| Q34455486 | Resolvin D1 reverses chronic pancreatitis-induced mechanical allodynia, phosphorylation of NMDA receptors, and cytokines expression in the thoracic spinal dorsal horn |
| Q37376506 | Role of interleukin-1beta during pain and inflammation |
| Q40613981 | Schizophrenia susceptibility pathway neuregulin 1-ErbB4 suppresses Src upregulation of NMDA receptors. |
| Q36809843 | Seizure-Induced Regulations of Amyloid-β, STEP61, and STEP61 Substrates Involved in Hippocampal Synaptic Plasticity. |
| Q88683766 | Separate functional properties of NMDARs regulate distinct aspects of spatial cognition |
| Q47322794 | Septal Cholinergic Neuromodulation Tunes the Astrocyte-Dependent Gating of Hippocampal NMDA Receptors to Wakefulness |
| Q30579310 | Signaling adaptor protein SH2B1 enhances neurite outgrowth and accelerates the maturation of human induced neurons |
| Q30449945 | Significant association of glutamate receptor, ionotropic N-methyl-D-aspartate 3A (GRIN3A), with nicotine dependence in European- and African-American smokers |
| Q35514668 | Specific sites within the ligand-binding domain and ion channel linkers modulate NMDA receptor gating |
| Q37426010 | Spinal astrocytic activation contributes to mechanical allodynia in a rat model of cyclophosphamide-induced cystitis |
| Q37749634 | Spinal cord mechanisms of chronic pain and clinical implications |
| Q30373373 | Structural insights into phenylethanolamines high-affinity binding site in NR2B from binding and molecular modeling studies. |
| Q37184815 | Structural rearrangements of NR1/NR2A NMDA receptors during allosteric inhibition. |
| Q27658149 | Structure of the zinc-bound amino-terminal domain of the NMDA receptor NR2B subunit |
| Q36276693 | Structure-activity relationships and pharmacophore model of a noncompetitive pyrazoline containing class of GluN2C/GluN2D selective antagonists |
| Q43161181 | Subchronic pharmacological and chronic genetic NMDA receptor hypofunction differentially regulate the Akt signaling pathway and Arc expression in juvenile and adult mice |
| Q48262180 | Synaptic NMDA receptors in basolateral amygdala principal neurons are triheteromeric proteins: physiological role of GluN2B subunits |
| Q42462536 | Synaptic NR2A- but not NR2B-Containing NMDA Receptors Increase with Blockade of Ionotropic Glutamate Receptors |
| Q37131124 | Synaptic plasticity in learning and memory: stress effects in the hippocampus. |
| Q37983237 | Synaptic plasticity of NMDA receptors: mechanisms and functional implications. |
| Q35787638 | Synaptic release and extracellular actions of Zn2+ limit propagation of spreading depression and related events in vitro and in vivo |
| Q92946450 | Synthesis and Characterization in Rodent Brain of the Subtype-Selective NR2B NMDA Receptor Ligand [11C]Ro04-5595 as a Potential Radiotracer for Positron Emission Tomography |
| Q88879305 | Synthesis and Pharmacological Evaluation of Enantiomerically Pure GluN2B Selective NMDA Receptor Antagonists |
| Q48108647 | Synthesis and in vitro characterisation of ifenprodil-based fluorescein conjugates as GluN1/GluN2B N-Methyl-D-aspartate receptor antagonists. |
| Q92431363 | Synthesis and receptor binding of thiophene bioisosteres of potent GluN2B ligands with a benzo[7]annulene-scaffold |
| Q58101274 | Synthesis of C5-tetrazole derivatives of 2-amino-adipic acid displaying NMDA glutamate receptor antagonism |
| Q36799584 | Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers |
| Q44223733 | Targeting GluN2B-containing N-Methyl-D-aspartate receptors: design, synthesis, and binding affinity evaluation of novel 3-substituted indoles |
| Q37374352 | Targeting the NMDA receptor subunit NR2B for the treatment of neuropathic pain |
| Q30486732 | The Concise Guide to PHARMACOLOGY 2013/14: ligand-gated ion channels. |
| Q39999426 | The N-terminal domain modulates α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor desensitization |
| Q90022421 | The NMDA receptor intracellular C-terminal domains reciprocally interact with allosteric modulators |
| Q46408552 | The NMDAR subunit NR2B expression is modified in hippocampus after repetitive seizures. |
| Q36698148 | The blockade of NMDA receptor ion channels by ketamine is enhanced in developing rat cortical neurons |
| Q30474232 | The clinical implications of mouse models of enhanced anxiety. |
| Q47918037 | The effect of memantine on sleep architecture and psychiatric symptoms in patients with Alzheimer's disease |
| Q48663120 | The influence of calcium ions on nickel modulation of NMDA receptor currents |
| Q35242214 | The intrinsic pathogenic role of autoantibodies to aquaporin 4 mediating spinal cord disease in a rat passive-transfer model |
| Q48592894 | The major cholesterol metabolite cholestane-3β,5α,6β-triol functions as an endogenous neuroprotectant. |
| Q38218392 | The multifaceted subunit interfaces of ionotropic glutamate receptors |
| Q35236498 | The neuronal nitric oxide synthase (nNOS) gene and neuroprotection against alcohol toxicity |
| Q38286249 | The potential of targeting NMDA receptors outside the CNS. |
| Q43247737 | The role of NMDA receptor subtypes in short-term plasticity in the rat entorhinal cortex |
| Q28771352 | The serine protease plasmin cleaves the amino-terminal domain of the NR2A subunit to relieve zinc inhibition of the N-methyl-D-aspartate receptors |
| Q38022257 | The unique contribution of ion channels to platelet and megakaryocyte function |
| Q51654191 | Tonically active NMDA receptors--a signalling mechanism critical for interneuronal excitability in the CA1 stratum radiatum. |
| Q36699036 | Treatment with a clinically-relevant dose of methylphenidate alters NMDA receptor composition and synaptic plasticity in the juvenile rat prefrontal cortex. |
| Q90595279 | Triheteromeric GluN1/GluN2A/GluN2C NMDARs with Unique Single-Channel Properties Are the Dominant Receptor Population in Cerebellar Granule Cells |
| Q42574995 | Triheteromeric NMDA receptors at hippocampal synapses |
| Q42120726 | Tropisetron as a neuroprotective agent against glutamate-induced excitotoxicity and mechanisms of action |
| Q42177814 | Tyrosine Phosphorylation of NR2B Contributes to Chronic Migraines via Increased Expression of CGRP in Rats |
| Q37224558 | Update on the use of memantine in Alzheimer's disease |
| Q27658372 | X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor |
| Q42598082 | Zinc effects on NMDA receptor gating kinetics. |
| Q60049739 | Zinc enhances hippocampal long-term potentiation at CA1 synapses through NR2B containing NMDA receptors |
| Q34509219 | Zinc reverses glycine-dependent inactivation of NMDARs in cultured rat hippocampal neurons |
| Q48483880 | Zinc transporter-1: a novel NMDA receptor-binding protein at the postsynaptic density |
| Q41325815 | [EXPRESS] Enhancement of spinal dorsal horn neuron NMDA receptor phosphorylation as the mechanism of remifentanil induced hyperalgesia: Roles of PKC and CaMKII. |
Search more.